Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Bought by Versant Capital Management Inc

Versant Capital Management Inc grew its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 73.3% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,192 shares of the medical equipment provider's stock after purchasing an additional 504 shares during the quarter. Versant Capital Management Inc's holdings in Intuitive Surgical were worth $590,000 as of its most recent SEC filing.

Other institutional investors have also modified their holdings of the company. Brighton Jones LLC raised its stake in Intuitive Surgical by 24.9% during the fourth quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider's stock worth $1,916,000 after purchasing an additional 731 shares during the period. Union Bancaire Privee UBP SA acquired a new position in shares of Intuitive Surgical in the fourth quarter valued at approximately $6,509,000. Mount Yale Investment Advisors LLC grew its holdings in shares of Intuitive Surgical by 5.7% in the fourth quarter. Mount Yale Investment Advisors LLC now owns 484 shares of the medical equipment provider's stock valued at $253,000 after purchasing an additional 26 shares in the last quarter. Foundations Investment Advisors LLC increased its position in shares of Intuitive Surgical by 96.6% in the 4th quarter. Foundations Investment Advisors LLC now owns 1,160 shares of the medical equipment provider's stock valued at $605,000 after purchasing an additional 570 shares during the last quarter. Finally, Asset Dedication LLC increased its position in shares of Intuitive Surgical by 94.2% in the 4th quarter. Asset Dedication LLC now owns 534 shares of the medical equipment provider's stock valued at $279,000 after purchasing an additional 259 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company's stock.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on ISRG. Truist Financial reduced their target price on shares of Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating for the company in a research note on Wednesday, April 23rd. Citigroup restated a "buy" rating and issued a $650.00 target price (up previously from $590.00) on shares of Intuitive Surgical in a research note on Thursday, May 22nd. Piper Sandler reduced their price objective on shares of Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating for the company in a research note on Wednesday, April 23rd. Erste Group Bank downgraded shares of Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a report on Monday, March 17th. Finally, Evercore ISI lowered their price target on shares of Intuitive Surgical from $510.00 to $470.00 and set an "in-line" rating for the company in a report on Wednesday, April 23rd. Five analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $596.05.

Insider Buying and Selling at Intuitive Surgical

In other news, EVP Myriam Curet sold 3,031 shares of the company's stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $577.30, for a total transaction of $1,749,796.30. Following the completion of the transaction, the executive vice president now owns 353 shares in the company, valued at approximately $203,786.90. This represents a 89.57% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Jami K. Nachtsheim sold 2,400 shares of the company's stock in a transaction dated Thursday, May 1st. The stock was sold at an average price of $520.00, for a total transaction of $1,248,000.00. Following the completion of the sale, the director now directly owns 6,371 shares of the company's stock, valued at $3,312,920. The trade was a 27.36% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 30,111 shares of company stock worth $15,364,055 over the last 90 days. Insiders own 0.70% of the company's stock.

Intuitive Surgical Price Performance

ISRG traded down $4.61 during trading on Friday, hitting $551.14. The company had a trading volume of 2,091,011 shares, compared to its average volume of 1,646,559. The company has a market cap of $197.54 billion, a PE ratio of 85.98, a P/E/G ratio of 5.85 and a beta of 1.70. The business has a 50-day moving average of $516.44 and a 200-day moving average of $538.53. Intuitive Surgical, Inc. has a 1-year low of $397.47 and a 1-year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, beating the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. The firm had revenue of $2.25 billion during the quarter, compared to analyst estimates of $2.19 billion. During the same quarter in the previous year, the firm earned $1.50 earnings per share. Research analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.